These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Use of a prescribed ephedrine/caffeine combination and the risk of serious cardiovascular events: a registry-based case-crossover study. Hallas J; Bjerrum L; Støvring H; Andersen M Am J Epidemiol; 2008 Oct; 168(8):966-73. PubMed ID: 18756018 [TBL] [Abstract][Full Text] [Related]
4. Thermal regulation in the heat during exercise after caffeine and ephedrine ingestion. Bell DG; Jacobs I; McLellan TM; Miyazaki M; Sabiston CM Aviat Space Environ Med; 1999 Jun; 70(6):583-8. PubMed ID: 10373050 [TBL] [Abstract][Full Text] [Related]
8. Complicated hypertension related to the abuse of ephedrine and caffeine alkaloids. Berman JA; Setty A; Steiner MJ; Kaufman KR; Skotzko C J Addict Dis; 2006; 25(3):45-8. PubMed ID: 16956868 [TBL] [Abstract][Full Text] [Related]
9. [Letigen, insulin resistance and treatment of obesity--again]. Richelsen B Ugeskr Laeger; 2002 Oct; 164(42):4944-5. PubMed ID: 12416081 [No Abstract] [Full Text] [Related]
10. [Ephedrine and ephedra in weight loss products and other preparations]. van der Hooft CS; Stricker BH Ned Tijdschr Geneeskd; 2002 Jul; 146(28):1335-6. PubMed ID: 12148223 [TBL] [Abstract][Full Text] [Related]
11. Stimulants and sudden death: what is the real risk? Furman L Pediatrics; 2007 Feb; 119(2):409; author reply 409-10. PubMed ID: 17272634 [No Abstract] [Full Text] [Related]
12. [Unexpected sudden death and coronary lesions. Apropos of 407 cases out of 1000 deaths in patients under 65 years of age]. Tabib A; Loire R Arch Mal Coeur Vaiss; 1993 Apr; 86(4):401-6. PubMed ID: 8239866 [TBL] [Abstract][Full Text] [Related]
13. Exercise-related sudden death due to an unusual coronary artery anomaly. Iskandar EG; Thompson PD Med Sci Sports Exerc; 2004 Feb; 36(2):180-2. PubMed ID: 14767237 [TBL] [Abstract][Full Text] [Related]
14. Stimulant-drug therapy for attention-deficit disorder (with or without hyperactivity) and sudden cardiac death. Knight M Pediatrics; 2007 Jan; 119(1):154-5. PubMed ID: 17200281 [No Abstract] [Full Text] [Related]
15. "All but death, can be adjusted". Ma Huang (ephedrine) adversities. Mack RB N C Med J; 1997; 58(1):68-70. PubMed ID: 9019118 [No Abstract] [Full Text] [Related]
16. Stimulants and sudden death: what is a physician to do? Wilens TE; Prince JB; Spencer TJ; Biederman J Pediatrics; 2006 Sep; 118(3):1215-9. PubMed ID: 16951018 [TBL] [Abstract][Full Text] [Related]
18. [Unexpected sudden cardiac death. An evaluation of 1000 autopsies]. Loire R; Tabib A Arch Mal Coeur Vaiss; 1996 Jan; 89(1):13-18. PubMed ID: 8678733 [TBL] [Abstract][Full Text] [Related]
19. [The retrospective study of sudden cardiac death in 118 cases]. He K; Xu JS; Wang ZY Fa Yi Xue Za Zhi; 2007 Aug; 23(4):299-301. PubMed ID: 17896526 [TBL] [Abstract][Full Text] [Related]
20. Ephedrine use is risky business. Landry GL Curr Sports Med Rep; 2003 Feb; 2(1):1-2. PubMed ID: 12831669 [No Abstract] [Full Text] [Related] [Next] [New Search]